Banking

Maravai Lifesciences Shows Rising Relative Strength During Breakout

When looking for the best stocks to buy and watch, focus on those with rising relative price strength.

One stock that fits that bill is Maravai Lifesciences (MRVI), which saw a welcome improvement to its Relative Strength (RS) Rating on Thursday, with an increase from 89 to 93.

When you’re researching the best stocks to buy and watch, be sure to pay attention to relative price strength. This exclusive rating from Investor’s Business Daily measures share price performance with a 1 (worst) to 99 (best) score. The grade shows how a stock’s price movement over the last 52 weeks compares to all the other stocks in our database.

Decades of market research shows that the top-performing stocks often have an RS Rating north of 80 at the beginning of a new price run.


Looking For The Best Stocks To Buy And Watch? Start Here


The IBD 50 stock is now considered extended and out of buy range after clearing a 45.89 buy point in a second-stage cup without handle. See if the stock forms a new pattern or follow-on buying opportunity like a three-weeks tight or pullback to the 50-day or 10-week line.

The company saw both earnings and sales growth rise last quarter. Earnings-per-share increased from 0% to 167%. Revenue rose from 173% to 191%.

Maravai Lifesciences holds the No. 1 rank among its peers in the Medical-Biomed/Biotech industry group. Innoviva (INVA) is also among the group’s highest-rated stocks.

YOU MIGHT ALSO LIKE:

Join IBD Live And Learn Top Chart-Reading And Trading Techniques From The Pros
MarketSmith’s Tools Can Help The Individual Investor
Profit From Short-Term Trends With SwingTrader
Get Timely Buy & Sell Alerts With IBD Leaderboard
Find The Best Long-Term Investments With IBD Long-Term Leaders

 

Most Related Links :
usanewswall Governmental News Finance News

Source link

Back to top button